Clinical Scorecard: Postop Pain Differs by Vitamin D Status
At a Glance
| Category | Detail |
|---|---|
| Condition | Postoperative Pain in Breast Cancer Surgery |
| Key Mechanisms | Association between preoperative vitamin D levels and postoperative pain severity. |
| Target Population | Female patients aged 20 to 65 years with newly diagnosed breast cancer scheduled for elective surgery. |
| Care Setting | Single center in Egypt. |
Key Highlights
- 17% of vitamin D-deficient patients reported moderate to severe pain at 12 hours postsurgery compared to 2% in the sufficient group.
- Vitamin D deficiency was associated with more than three times the odds of moderate to severe postoperative pain.
- Postoperative nausea was more prevalent in the vitamin D-deficient group.
- Mean postoperative tramadol consumption was higher in the vitamin D-deficient group (381 mg vs 268 mg).
- No patients experienced severe pain (NRS score of 7 or greater) during the study.
Guideline-Based Recommendations
Diagnosis
- Categorize patients based on preoperative serum 25-hydroxyvitamin D levels.
Management
- Implement standardized anesthesia and postoperative analgesia protocols.
Monitoring & Follow-up
- Assess postoperative pain using the Numerical Rating Scale at multiple time points.
Risks
- Monitor for increased postoperative pain and nausea in vitamin D-deficient patients.
Patient & Prescribing Data
184 female patients with breast cancer undergoing surgery.
Standardized protocols included intravenous paracetamol and patient-controlled tramadol analgesia.
Clinical Best Practices
- Consider vitamin D status in preoperative assessments for breast cancer surgery.
- Monitor pain levels closely in the immediate postoperative period.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
